Kayne Anderson Rudnick Investment Management
CNTA

Kayne Anderson Rudnick Investment Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-80
Closed -$1K – 616
2022
Q1 		$1K Buy
+80
New +$1K ﹤0.01% 622